HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshihiro Kimura Selected Research

Cytokines

2/2021Immunotherapy with 4-1BBL-Expressing iPS Cell-Derived Myeloid Lines Amplifies Antigen-Specific T Cell Infiltration in Advanced Melanoma.
1/2020PD-1+ Tim3+ tumor-infiltrating CD8 T cells sustain the potential for IFN-γ production, but lose cytotoxic activity in ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshihiro Kimura Research Topics

Disease

21Neoplasms (Cancer)
09/2021 - 09/2004
10Melanoma (Melanoma, Malignant)
09/2021 - 07/2016
8Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2022 - 09/2004
8Endometrial Neoplasms (Endometrial Cancer)
06/2022 - 09/2008
6Ovarian Neoplasms (Ovarian Cancer)
09/2021 - 06/2010
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2022 - 05/2007
3Infections
12/2022 - 12/2002
3Inflammation (Inflammations)
09/2021 - 02/2011
3Hyperglycemia
05/2016 - 11/2015
3Carcinoma (Carcinomatosis)
06/2013 - 12/2011
2Papillomavirus Infections
12/2022 - 09/2004
2Uterine Cervical Dysplasia
12/2022 - 05/2012
2Leiomyosarcoma
01/2021 - 01/2020
2Myasthenia Gravis
11/2018 - 07/2016
2Myositis (Idiopathic Inflammatory Myopathies)
11/2018 - 07/2016
2Type 2 Diabetes Mellitus (MODY)
10/2018 - 01/2016
2Neoplasm Metastasis (Metastasis)
07/2016 - 10/2005
2Abdominal Obesity
01/2016 - 11/2015
2Hypertriglyceridemia
01/2016 - 11/2015
2Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016 - 11/2015
2Hypertension (High Blood Pressure)
01/2016 - 11/2015
2Cardiovascular Diseases (Cardiovascular Disease)
05/2015 - 10/2012
2Carcinogenesis
05/2007 - 09/2004
1Microsatellite Instability
02/2022
1Postpartum Hemorrhage
09/2021
1AIDS-Related Complex (ARC)
09/2021
1Experimental Melanoma
01/2020
1Extramammary Paget Disease (Paget Disease, Extramammary)
01/2020
1Liposarcoma
12/2019
1Necrosis
12/2019
1Sclerosing Cholangitis
07/2019
1Colitis
01/2019

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
06/2021 - 06/2010
5Immune Checkpoint InhibitorsIBA
09/2021 - 07/2016
5PlatinumIBA
09/2021 - 09/2012
5Proteins (Proteins, Gene)FDA Link
04/2021 - 09/2004
5Paclitaxel (Taxol)FDA LinkGeneric
07/2019 - 12/2011
3AntigensIBA
02/2021 - 01/2020
3AntibodiesIBA
01/2021 - 07/2016
3NivolumabIBA
01/2019 - 07/2016
3Pharmaceutical PreparationsIBA
04/2016 - 01/2007
3Carboplatin (JM8)FDA LinkGeneric
01/2015 - 05/2012
3taxaneIBA
06/2013 - 09/2012
3Messenger RNA (mRNA)IBA
09/2008 - 09/2004
2Papillomavirus Vaccines (HPV Vaccines)IBA
12/2022 - 01/2021
2Monoclonal AntibodiesIBA
06/2022 - 01/2021
2Immunoconjugates (Immunoconjugate)IBA
09/2021 - 01/2021
2Cisplatin (Platino)FDA LinkGeneric
09/2021 - 12/2011
2DNA (Deoxyribonucleic Acid)IBA
06/2021 - 01/2011
2Peptides (Polypeptides)IBA
02/2021 - 01/2020
2CytokinesIBA
02/2021 - 01/2020
2HDL CholesterolIBA
01/2016 - 11/2015
2CalciumIBA
05/2015 - 01/2007
2Tumor Biomarkers (Tumor Markers)IBA
11/2012 - 06/2010
2AnthracyclinesIBA
10/2012 - 05/2012
2Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2011 - 09/2004
2Cyclin-Dependent Kinase Inhibitor p16IBA
01/2011 - 09/2004
1VaccinesIBA
12/2022
1Lipoprotein Receptors (Lipoprotein Receptor)IBA
06/2022
1PromegaIBA
02/2022
1SuspensionsIBA
11/2021
1Indicators and Reagents (Reagents)IBA
09/2021
1Lactic Acid (Lactate)FDA LinkGeneric
09/2021
1Early Growth Response Protein 1IBA
09/2021
1Cell-Free Nucleic AcidsIBA
06/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2021
1Interferon-betaIBA
05/2021
1Interleukin-15 Receptor alpha SubunitIBA
05/2021
1Interleukin-15 (Interleukin 15)IBA
05/2021
1Nucleosomes (Nucleosome)IBA
04/2021
1EpitopesIBA
02/2021
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2021
1monomethylauristatin FIBA
01/2021
1Small Interfering RNA (siRNA)IBA
11/2020
1Neoplasm Antigens (Tumor Antigens)IBA
01/2020
1Biosimilar PharmaceuticalsIBA
01/2020
1OX40 LigandIBA
01/2020
1MicroRNAs (MicroRNA)IBA
01/2020
1Trastuzumab (Herceptin)FDA Link
01/2020
1IonsIBA
01/2020
1Copper Sulfate (Sulfate, Copper)FDA Link
01/2020
1Docetaxel (Taxotere)FDA Link
01/2020
1Immune Checkpoint ProteinsIBA
01/2020
1CopperIBA
01/2020
1Adenosine Triphosphatases (ATPase)IBA
01/2020
1OvalbuminIBA
01/2020
1DesminIBA
12/2019
1A 7 (A-7)IBA
12/2019
1Contrast MediaIBA
12/2019
1Bevacizumab (Avastin)FDA Link
07/2019
1ZincIBA
10/2018

Therapy/Procedure

9Drug Therapy (Chemotherapy)
07/2019 - 06/2011
8Therapeutics
04/2021 - 01/2007
4Combination Drug Therapy (Combination Chemotherapy)
01/2020 - 12/2011
3Immunotherapy
02/2021 - 01/2020
2Cell- and Tissue-Based Therapy (Cell Therapy)
05/2021 - 02/2021
2Aftercare (After-Treatment)
02/2021 - 05/2012
2Lung Transplantation
01/2004 - 12/2002
2Home Parenteral Nutrition
01/2004 - 12/2002
1Injections
02/2021